MARKET

CDXC

CDXC

ChromaDex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.000
-0.260
-7.98%
After Hours: 3.000 0 0.00% 16:00 04/01 EDT
OPEN
3.050
PREV CLOSE
3.260
HIGH
3.230
LOW
2.950
VOLUME
368.44K
TURNOVER
--
52 WEEK HIGH
4.950
52 WEEK LOW
2.500
MARKET CAP
179.36M
P/E (TTM)
-5.3229
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CDXC stock price target is 7.38 with a high estimate of 10.50 and a low estimate of 6.00.

EPS

CDXC News

More
  • Cellular Health Market Leader Tru Niagen® Launches Online in Australia
  • GlobeNewswire · 03/23 11:30
  • Edited Transcript of CDXC earnings conference call or presentation 10-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 03/16 07:56
  • US$7.38: That's What Analysts Think ChromaDex Corporation Is Worth After Its Latest Results
  • Simply Wall St. · 03/13 11:57
  • ChromaDex Corrects Statements Made by an Unaffiliated Third Party Regarding its Product and COVID-19
  • GlobeNewswire · 03/12 21:44

Industry

Biotechnology & Medical Research
-4.51%
Pharmaceuticals & Medical Research
-2.97%

Hot Stocks

Symbol
Price
%Change

About CDXC

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
More

Webull offers kinds of Chromadex Corp stock information, including NASDAQ:CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions.